Unsafe Medical Devices
Each year, The U.S. Food and Drug Administration (“FDA”) receives several hundred thousand reports of malfunctions, serious injuries and deaths suspected of being associated with defective medical devices. These reports — known as “Adverse Event Reports” — sometimes lead to recalls of dangerous or defective medical devices.
If a medical device manufacturer discovers a defect in one of its products, the manufacturer is required to notify the FDA and the public. This duty begins with the development of the medical device, and it continues for as long as the medical device remains on the market. If a medical device manufacturer fails to properly to notify the FDA and the public of a defect with one of its products, it can held responsible for illnesses, injuries and deaths caused by the faulty medical device.
For more information, see our Unsafe Medical Device FAQ.
Often, medical devices are implanted in the body. If a defective medical device is discovered after the device has been implanted, the device sometimes must be removed from the body, or “explanted.” This procedure is called a “revision surgery” and it subjects the patient to additional pain, risk of infection and prolonged rehabilitation.
If you or a loved one has been harmed by a unsafe medical device, contact us for a free consultation.
RECENT BLOG POSTS FOR DEFECTIVE MEDICAL DEVICES
Defective medical devices update: In March 2015, the United States Food and Drug Administration issued a recall for nearly 12,000 Zimmer Persona Trabecular Metal Tibial Plate knee implants. One month earlier, Zimmer sent an Urgent Medical Device Recall...read more
A national settlement of Stryker hip replacment claims was announced yesterday. The total estimated settlement for the defective hip implants may exceed $1 billion.The settlement provides for the largest base payment award for any mass tort hip implants. People...read more
The first bellwether trials in the Stryker defective hip replacements litigation have been scheduled. Two trials have been scheduled for June 15, 2015 and July 13, 2015 in the Superior Court of Bergen County, New Jersey.Bellwether trials are a common practice in mass...read more
In light of mounting concerns and growing debate over laparoscopic power morcellators, a major health insurance company has announced that it will no longer cover the procedure. Highmark, Inc. announced that, effective September 1, 2014, it will cease coverage for...read more
On Wednesday, pharmaceutical giant Johnson & Johnson announced plans to ask doctors to return all Ethicon laparoscopic power morcellators. The company is calling the voluntary move "a worldwide market withdrawal" of Ethicon morcillation. Ethicon, a division of...read more
A new study has provided additional evidence to support the Food and Drug Administration's warnings regarding laparoscopic power morcellators used in hysterectomies.A Columbia University study that was published on July 22 in the Journal of the American Medical...read more